Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
State Opioid Response Grants
The Substance Abuse and Mental Health Services Administration (SAMHSA) is accepting applications for fiscal year (FY) 2018 State Opioid Response Grants (Short Title:
SOR).
The program aims to address the opioid crisis by increasing access to medication-assisted treatment using the three FDA-approved
medications for the treatment of opioid use disorder, reducing unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD) (including prescription opioids, heroin and illicit fentanyl and fentanyl analogs).
These grants will be awarded to states and territories via formula.
The program also includes a 15 percent set-aside for the ten states with the highest mortality rate related to drug overdose deaths.
Grantees will be required to do the following:
use epidemiological data to demonstrate the critical gaps in availability of treatment for OUDs in geographic, demographic, and service level terms; utilize evidence-based implementation strategies to identify which system design models will most rapidly and adequately address the gaps in their systems of care; deliver evidence-based treatment interventions that include medication(s) FDA-approved specifically for the treatment of OUD, and psychosocial interventions; report progress toward increasing availability of medication-assisted treatment for OUD; and reducing opioid-related overdose deaths.
The program supplements activities pertaining to opioids currently undertaken by the state agency and will support a comprehensive response to the opioid epidemic.
The results of the assessments will identify gaps and resources from which to build upon existing substance use prevention and treatment activities as well as community-based recovery support services.
Grantees will be required to describe how they will expand access to treatment and recovery support services.
Grantees will also be required to describe how they will advance substance misuse prevention in coordination with other federal efforts.
Grantees must use funding to supplement and not supplant existing opioid prevention, treatment, and recovery activities in their state.
Grantees are required to describe how they will improve retention in care, using a chronic care model or other innovative model that has been shown to improve retention in care.
SOR).
The program aims to address the opioid crisis by increasing access to medication-assisted treatment using the three FDA-approved
medications for the treatment of opioid use disorder, reducing unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD) (including prescription opioids, heroin and illicit fentanyl and fentanyl analogs).
These grants will be awarded to states and territories via formula.
The program also includes a 15 percent set-aside for the ten states with the highest mortality rate related to drug overdose deaths.
Grantees will be required to do the following:
use epidemiological data to demonstrate the critical gaps in availability of treatment for OUDs in geographic, demographic, and service level terms; utilize evidence-based implementation strategies to identify which system design models will most rapidly and adequately address the gaps in their systems of care; deliver evidence-based treatment interventions that include medication(s) FDA-approved specifically for the treatment of OUD, and psychosocial interventions; report progress toward increasing availability of medication-assisted treatment for OUD; and reducing opioid-related overdose deaths.
The program supplements activities pertaining to opioids currently undertaken by the state agency and will support a comprehensive response to the opioid epidemic.
The results of the assessments will identify gaps and resources from which to build upon existing substance use prevention and treatment activities as well as community-based recovery support services.
Grantees will be required to describe how they will expand access to treatment and recovery support services.
Grantees will also be required to describe how they will advance substance misuse prevention in coordination with other federal efforts.
Grantees must use funding to supplement and not supplant existing opioid prevention, treatment, and recovery activities in their state.
Grantees are required to describe how they will improve retention in care, using a chronic care model or other innovative model that has been shown to improve retention in care.
Agency: Department of Health and Human Services
Office: Substance Abuse and Mental Health Services Adminis
Estimated Funding: $2,000,000
Office: Substance Abuse and Mental Health Services Adminis
Estimated Funding: $2,000,000
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PA-08-242.html
Additional Information of Eligibility:
Please note that Tribes will be eligible to apply for opioid response funding under a separate announcement.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PA-08-242.html
Contact:
Agency Email Description:
FOACSAT@samhsa.hhs.gov
Agency Email:
Date Posted:
2018-06-14
Application Due Date:
Archive Date:
2018-09-12
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
